Humacyte, Inc. Shares Outstanding
Humacyte, Inc. (HUMA) had Shares Outstanding of 277.80 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-12
- 2026-06-30: Shares outstanding (split-adjusted) 277.80M shares; Shares authorized (split-adjusted) 550.00M shares.
- 2026-06-29: Shares outstanding (split-adjusted) (m); Shares authorized (split-adjusted) 350.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 222.02M shares; Shares authorized (split-adjusted) 350.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 193.00M shares; Shares authorized (split-adjusted) 350.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 277.80M shares 10-Q · filed 2026-08-12 | 550.00M shares 10-Q · filed 2026-08-12 |
| 2026-06-29 | (m) | 350.00M shares 10-Q · filed 2026-08-12 |
| 2026-03-31 | 222.02M shares 10-Q · filed 2026-05-13 | 350.00M shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 193.00M shares 10-Q · filed 2026-08-12 | 350.00M shares 10-Q · filed 2026-08-12 |
| 2025-09-30 | 158.84M shares 10-Q · filed 2025-11-12 | 350.00M shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 156.34M shares 10-Q · filed 2025-08-11 | 350.00M shares 10-Q · filed 2026-05-13 |
| 2025-06-29 | (m) | 250.00M shares 10-Q · filed 2026-05-13 |
| 2025-03-31 | 155.12M shares 10-Q · filed 2025-05-13 | 250.00M shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 130.03M shares 10-K · filed 2026-03-27 | 250.00M shares 10-K · filed 2026-03-27 |
| 2024-09-30 | 119.84M shares 10-Q · filed 2024-11-08 | 250.00M shares 10-Q · filed 2024-11-08 |
| 2024-06-30 | 119.35M shares 10-Q · filed 2024-08-13 | 250.00M shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 119.08M shares 10-Q · filed 2024-05-13 | 250.00M shares 10-Q · filed 2024-05-13 |
| 2023-12-31 | 103.67M shares 10-K · filed 2025-03-31 | 250.00M shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 103.46M shares 10-Q · filed 2023-11-09 | 250.00M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 103.41M shares 10-Q · filed 2023-08-14 | 250.00M shares 10-Q · filed 2023-08-14 |
| 2023-03-31 | 103.33M shares 10-Q · filed 2023-05-12 | 250.00M shares 10-Q · filed 2023-05-12 |
| 2022-12-31 | 103.23M shares 10-K · filed 2024-03-28 | 250.00M shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 103.10M shares 10-Q · filed 2022-11-10 | 250.00M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 103.01M shares 10-Q · filed 2022-08-12 | 250.00M shares 10-Q · filed 2022-08-12 |
| 2022-03-31 | 103.00M shares 10-Q · filed 2022-05-13 | 250.00M shares 10-Q · filed 2022-05-13 |
| 2021-12-31 | 103.00M shares 10-K · filed 2023-03-24 | 250.00M shares 10-K · filed 2023-03-24 |
| 2021-09-30 | 103.00M shares 10-Q · filed 2021-11-15 | 250.00M shares 10-Q · filed 2021-11-15 |
| 2021-08-26 | 103.00M shares 10-Q · filed 2024-05-13 | (m) |
| 2020-12-31 | 5.82M shares 10-K · filed 2022-03-29 | 340.22M shares 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |